Protagonist Therapeutics, Inc 10-K for FY2024
Protagonist Therapeutics, Inc (PTGX)
10-K
2025-02-21
For: 2024-12-31
View Original
Added on
April 07, 2026
About this 10-K
Protagonist Therapeutics, Inc filed this 10-K on February 21, 2025, covering the fiscal year ended December 31, 2024 (FY2024).
Headline figures
Fiscal year ended December 31, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $434.43M
- up 624.1% from $60M a year earlier
- Net income
- $275.19M
- compared with a net loss of $78.96M a year earlier
- Diluted EPS
- $4.23
- compared with -$1.39 a year earlier